Skip to main content
MKKGY logo

Merck KGaA (MKKGY) Stock Price & Analysis

Merck KGaA (MKKGY) — price $32.49 (-1.10%), as of the Nov 19, 2026 trading session; market cap $70.6B.

Educational signal · not a buy or sell recommendation · How to read this

$32.49 −$0.36 (-1.10%) Market Cap $70.6B

Merck KGaA · MKKGY · Healthcare · Drug Manufacturers - Specialty & Generic

Merck KGaA is a leading German science and technology enterprise. Its business operations are strategically organized into three core divisions: Life Science, Healthcare, and Electronics.

Price as of Nov 19, 2026

Key Statistics

No MoonshotScore yet: we have not published a score for this company.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • TAK · Takeda Pharmaceutical Company Limited · 73 /100
  • TEVA · Teva Pharmaceutical Industries Limited · 57 /100
  • HLN · Haleon plc · 75 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$32.49
Change on the day-1.10%
52-week range$23.73–$34.19
Market capitalisation$70.6B—
Price / earnings (trailing)27.66
Shares traded on the day1.8K
Beta (volatility vs the S&P 500)0.81

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $24, high $34, latest $32. $34 $24 high $34 Oct 17, 2025 Nov 19, 2026 · $32 $26Oct 17, 2025$26Oct 31, 2025$28Nov 14, 2025$27Nov 28, 2025$28Dec 12, 2025$29Dec 26, 2025$30Jan 9, 2026$30Jan 23, 2026$29Feb 6, 2026$30Feb 20, 2026$26Mar 6, 2026$24Mar 20, 2026$25Apr 2, 2026$28Apr 17, 2026$26May 1, 2026$27May 15, 2026$30May 29, 2026$31Jun 12, 2026$33Jun 26, 2026$32Jul 10, 2026$32Jul 24, 2026$33Aug 7, 2026$32Aug 21, 2026$32Sep 4, 2026$30Sep 18, 2026$31Oct 2, 2026$32Oct 16, 2026$34Oct 30, 2026$33Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Merck KGaA (MKKGY): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 10, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Neutral
Revenue Growth Negative
Debt/Equity Neutral
ROE Neutral
Gross Margin Moderate

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 11, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Merck KGaA (MKKGY), and what does it report?

Short answer · as of

Life Science sells tools, chemicals, equipment, testing products, and process expertise to researchers, biotechnology companies, drug manufacturers, and industrial customers.

Research dated 2026-09-12.

Healthcare develops and commercializes medicines across oncology, neurology, immunology, fertility, endocrinology, and other therapeutic areas, while Electronics supplies semiconductor and display materials alongside delivery systems and surface products.

2 · Latest results

What do the latest results show for Merck KGaA (MKKGY)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of €5.52B. Against analyst estimates the company has EPS beat 6 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026€5.52B€498M€0.23 (diluted)
Q1 FY2026€5.13B€659M€0.30 (diluted)
Q4 FY2025€5.20B€316M€0.14 (diluted)
Q3 FY2025€5.32B€902M€0.41 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Merck KGaA (MKKGY)?

Short answer · as of

The distress and quality screens read Altman Z 3.19 · Piotroski F 7. Trailing ratios: ROE 8.1% · ROA 4.5% · current ratio 1.69 · earnings yield 3.6% · free-cash-flow yield 4.1%.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held MKKGY in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported MKKGY in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Merck KGaA (MKKGY)?

Read these with our analysis →

What Investors Ask About Merck KGaA (MKKGY) — Healthcare

The last question is answered from this page's own dated data, not from the research.

Why is Merck KGaA more than a pharmaceutical manufacturer?

Prescription medicines sit alongside Life Science tools and bioprocessing expertise, plus Electronics materials used in semiconductor, display, and surface applications. Consolidated results therefore reflect laboratory activity and electronics production as well as medicine demand.

How can semiconductor customer bottlenecks affect Merck KGaA?

Merck KGaA supplies materials and delivery systems used by semiconductor customers, so constrained customer capacity can postpone material consumption and limit near-term sales conversion. Management expects those constraints to persist while the industry removes bottlenecks.

What is the MKKGY stock price today?

The last price recorded for Merck KGaA (MKKGY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 17 figures on this page — 13 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • 1. What is Merck KGaA (MKKGY), and what does it report?: Business description; Sector / industry (provider taxonomy)
  • FAQ: Why is Merck KGaA more than a pharmaceutical manufacturer?: Sector / industry (provider taxonomy); Business description
  • FAQ: How can semiconductor customer bottlenecks affect Merck KGaA?: Business description; Management outlook — dated call excerpts
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.